SEC Form 4 · accession 0001179110-15-013621
AMAG PHARMACEUTICALS INC. · AMAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William K Heiden
Officer — CEO · Director
Period of report
Oct 1, 2015
Accepted (ET)
Oct 2, 2015 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 1, 2015 | S | 2,000 | $39.69 | D | 200,721 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported transaction on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2015.